Company: PACB
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001299130-25-000168
Chunk: 5

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
ITEM 1.  FINANCIAL STATEMENTS

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)

(In thousands, except par value)September 30,2025December 31,2024AssetsCurrent assets Cash and cash equivalents $56,467 $55,370 Investments 242,187 334,561 Accounts receivable, net30,616 27,524 Inventory, net53,153 58,755 Prepaid expenses and other current assets 11,513 18,781 Short-term restricted cash300 690 Total current assets 394,236 495,681 Property and equipment, net 22,127 30,505 Operating lease right-of-use assets, net 42,583 16,091 Long-term restricted cash1,532 1,532 Intangible assets, net16,143 389,572 Goodwill317,761 317,761 Other long-term assets 8,776 9,305 Total assets $803,158 $1,260,447 Liabilities and Stockholders’ Equity Current liabilitiesAccounts payable $16,362 $16,590 Accrued expenses 29,172 22,595 Deferred revenue, current 16,049 13,864 Operating lease liabilities, current621 10,026 Other liabilities, current 1,005 3,224 Total current liabilities 63,209 66,299 Deferred revenue, non-current 4,400 5,900 Contingent consideration liability, non-current— 18,700 Operating lease liabilities, non-current 54,300 14,914 Convertible senior notes, net, non-current645,159 647,494 Other liabilities, non-current — 546 Total liabilities 767,068 753,853 Commitments and contingencies Stockholders’ equityPreferred stock, $0.001 par value:Authorized 50,000 shares; No shares issued or outstanding — — Common stock, $0.001 par value:Authorized 1,000,000 shares; issued and outstanding 301,853 and 294,418 shares at September 30, 2025 and December 31, 2024, respectively 302 294 Additional paid-in capital 2,690,304 2,654,804 Accumulated other